← Back to results
NCT05539976COMPLETED

A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants

An Open-label Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants

Sponsor: Bristol-Myers Squibb

No open prediction endpoints

Endpoints are classified and published by ProgramSignal analysts.

Request endpoint coverage

Key Facts

Study type
OBSERVATIONAL
Conditions
Healthy Participants
Interventions
Enrollment
10 participants
Primary completion
Nov 2022
Study completion
Nov 2022
First posted
Sep 2022
Last updated
Dec 2022

Primary Endpoints (CT.gov)

Taste Evaluation - Aromatic Identity

Time frame: Up to 3 Months

Taste Evaluation - Amplitude

Time frame: Up to 3 Months

Taste Evaluation - Mouthfeel

Time frame: Up to 3 Months

Taste Evaluation - Off-notes

Time frame: Up to 3 Months

Eligibility Criteria

Inclusion Criteria: * Participant is qualified based on training and experience. * Participants must be trained to detect, identify, recognize, and accurately describe different taste elements and flavor combinations. Training is initially accomplished by tasting model compounds and learning to recognize and describe these accurately. These abilities are then honed and refined through additional experience in performing taste profiling. * Participant is qualified based on training and experience. * Senopsys LLC will provide all participants. * Participants must be trained to detect, identify, recognize, and accurately describe different taste elements and flavor combinations. Training is initially accomplished by tasting model compounds and learning to recognize and describe these accurately. These abilities are then honed and refined through additional experience in performing taste profiling. Exclusion Criteria: * Participant has any history of any illness, medical condition, labo

Read full criteria on CT.gov →

✦ Analyst Commentary

Expert commentary on why this trial matters and what to watch for.

Request coverage →

Source

Open on ClinicalTrials.gov